definitely not B1 at this point
Additionally, GLP-1RAs therapy increases circulating vascular progenitor cell content while reducing proinflammatory granulocyte precursor levels, representing an additional mechanism underlying their cardioprotective effects (96)
Mechanistically, it influences gene networks involved in tissue remodeling and exerts protective antioxidant and anti-inflammatory actions, partly through TGF- signaling and regulation of metalloproteinases
Prioritize eating the following: 2530g protein per meal High fiber 100 oz of water daily Gentle meal structure Avoid greasy or heavy meals, which can worsen nausea
View trial here: e.lilly/3YDDwcg COMMIT-CD: A Phase 3b trial evaluating the efficacy & safety of concomitant use of a dual GLP-1/GIP receptor agonist & IL-23p19 antagonist in adult participants with moderately to severely active Crohn's disease & obesity, or overweight
These therapies aim to relieve pain and treat chronic pain at its biological roots, supporting true recovery instead of masking discomfort
